Literature DB >> 14577615

Characterization of a pseudogene for murine methylenetetrahydrofolate reductase.

Daniel Leclerc1, Hiba Darwich-Codore, Rima Rozen.   

Abstract

Methylenetetrahydrofolate reductase (MTHFR) reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the major carbon donor in the remethylation of homocysteine to methionine. Mild MTHFR deficiency, due to a common variant at nucleotide 677, has been reported to influence risk for several disorders including cardiovascular disease, neural tube defects, pregnancy complications and cancer. In recent work, we characterized the complete cDNA and gene sequences in the human and mouse genes, which had previously been mapped to chromosomes 1 and 4, respectively. During the course of this work, we observed that PCR primers in exons 1 and 2 of Mthfr generated amplicons of the expected size for the normal Mthfr transcript, using both reverse-transcribed RNA and genomic DNA as templates. These findings alluded to the existence of a pseudogene in the murine genome. Here, we report the characterization of this pseudogene. The absence of intron 1, the partial retention of intron 2, the location of this gene on chromosome 5, and the presence of sequences unrelated to Mthfr at the 5' and 3' ends of the 1259 bp fragment are features that are indicative of a partially-processed pseudogene, that we have designated Mthfr-ps. A Mthfr-ps transcript was not detectable by sensitive RT-PCR using assays designed to simultaneously detect the authentic Mthfr transcript. The structure of this paralogous gene and the identification of a repeat sequence at the 3' end of this pseudogene suggest that it arose by retrotransposition of a mis-spliced Mthfr transcript. Investigations of the Mthfr gene should take into account the presence of the non-functional Mthfr-ps to avoid misinterpretation of results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577615     DOI: 10.1023/a:1025540304067

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia.

Authors:  J L Wiemels; R N Smith; G M Taylor; O B Eden; F E Alexander; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations.

Authors:  K D Wenstrom; G L Johanning; K E Johnston; M DuBard
Journal:  Am J Obstet Gynecol       Date:  2001-04       Impact factor: 8.661

3.  The methylenetetrahydrofolate reductase (Mthfr) gene maps to distal mouse chromosome 4.

Authors:  P Frosst; Z Zhang; A Pai; R Rozen
Journal:  Mamm Genome       Date:  1996-11       Impact factor: 2.957

4.  Methylenetetrahydrofolate reductase thermolabile variant and oral clefts.

Authors:  J L Mills; P N Kirke; A M Molloy; H Burke; M R Conley; Y J Lee; P D Mayne; D G Weir; J M Scott
Journal:  Am J Med Genet       Date:  1999-09-03

5.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.

Authors:  Z Chen; A C Karaplis; S L Ackerman; I P Pogribny; S Melnyk; S Lussier-Cacan; M F Chen; A Pai; S W John; R S Smith; T Bottiglieri; P Bagley; J Selhub; M A Rudnicki; S J James; R Rozen
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

6.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

7.  Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)

Authors:  P Goyette; A Pai; R Milos; P Frosst; P Tran; Z Chen; M Chan; R Rozen
Journal:  Mamm Genome       Date:  1998-08       Impact factor: 2.957

Review 8.  Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences.

Authors:  B Schwahn; R Rozen
Journal:  Am J Pharmacogenomics       Date:  2001

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  4 in total

1.  Sirt2 epigenetically down-regulates PDGFRα expression and promotes CG4 cell differentiation.

Authors:  Na Fang; Junjun Cheng; Chu Zhang; Keyuan Chen; Chenyu Zhang; Zichao Hu; Ran Bi; Kendra L Furber; Merlin Thangaraj; Adil J Nazarali; Shaoping Ji
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

2.  Murine diet/tissue and human brain tumorigenesis alter Mthfr/MTHFR 5'-end methylation.

Authors:  Nancy Lévesque; Daniel Leclerc; Tenzin Gayden; Anthoula Lazaris; Nicolas De Jay; Stephanie Petrillo; Peter Metrakos; Nada Jabado; Rima Rozen
Journal:  Mamm Genome       Date:  2016-03-07       Impact factor: 2.957

3.  Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China.

Authors:  Shao-shuai Wang; Fu-yuan Qiao; Ling Feng; Juan-juan Lv
Journal:  J Zhejiang Univ Sci B       Date:  2008-02       Impact factor: 3.066

Review 4.  Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis.

Authors:  Vandana Rai; Upendra Yadav; Pradeep Kumar; Sushil K Yadav; Sanjay Gupta
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.